Table 2.
Changes in MASLD grade and metabolic syndrome over 6 months
| Outcome | Cholecystectomy group (n = 51) | P-value | Control group (n = 49) | P-value | ||
|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | |||
| MASLD grade, n (%): | 0.817 | |||||
| Normal | 24 (47.1) | 23 (45.1) | 20 (40.8) | 33 (67.3) | ||
| Mild (Grade 1) | 22 (43.1) | 25 (49.0) | 28 (57.1) | 13 (26.5) | ||
| Moderate (Grade 2) | 4 (7.8) | 2 (3.9) | 1 (2.0) | 3 (6.1) | ||
| Severe (Grade 3) | 1 (2.0) | 1 (2.0) | 0 (0) | 0 (0) | ||
| Metabolic syndrome, n(%) | 19 (37.7) | 28 (54.9) | 0.064 | 16 (32.7) | 9 (18.4) | 0.065 |
MASLD Metabolic dysfunction-Associated Steatotic Liver Disease